D. Lankler serves as the Executive Vice President and General Counsel at Pfizer Inc., a leading biopharmaceutical company. In this role, Lankler is responsible for overseeing the company's legal affairs, ensuring compliance with regulations, and providing strategic legal guidance to support Pfizer's global operations. With a strong background in corporate law and a deep understanding of the pharmaceutical industry, Lankler plays a crucial role in navigating the complex legal landscape that surrounds drug development, intellectual property, and corporate governance. Prior to joining Pfizer, Lankler held several high-level positions in the legal field. They began their career at a prestigious law firm, where they gained extensive experience in litigation, mergers and acquisitions, and corporate governance. Lankler's expertise in these areas has been instrumental in their success at Pfizer, allowing them to effectively manage the company's legal challenges and contribute to its overall strategic direction. Throughout their career, Lankler has been recognized for their leadership skills, legal acumen, and ability to foster a culture of integrity and compliance within the organizations they serve. As General Counsel at Pfizer, Lankler has been instrumental in guiding the company through various legal and regulatory challenges, including those related to the development and distribution of critical medications and vaccines. Their leadership has been particularly vital during the global response to the COVID-19 pandemic, where they have played a key role in ensuring that Pfizer's efforts to combat the virus are conducted in accordance with the highest legal and ethical standards. Lankler's dedication to the company's mission of improving global health, combined with their legal expertise, makes them an invaluable asset to Pfizer and its stakeholders.